Tomoaki Iwanaga

1.2k total citations
79 papers, 910 citations indexed

About

Tomoaki Iwanaga is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Tomoaki Iwanaga has authored 79 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 38 papers in Physiology and 12 papers in Epidemiology. Recurrent topics in Tomoaki Iwanaga's work include Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). Tomoaki Iwanaga is often cited by papers focused on Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). Tomoaki Iwanaga collaborates with scholars based in Japan, United States and United Kingdom. Tomoaki Iwanaga's co-authors include Hisamichi Aizawa, Yasushi Obase, Terufumi Shimoda, Tomoaki Hoshino, Tomotaka Kawayama, Reiko Kishikawa, Makoto Yoshida, Yuki Sakazaki, Masaki Okamoto and Yuzuru Inoue and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Tomoaki Iwanaga

75 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoaki Iwanaga Japan 18 485 363 179 112 97 79 910
D. Cox Ireland 17 457 0.9× 360 1.0× 402 2.2× 144 1.3× 82 0.8× 65 1.0k
N. Barnes United Kingdom 12 381 0.8× 491 1.4× 97 0.5× 147 1.3× 56 0.6× 31 854
Haruhiko Ogawa Japan 18 531 1.1× 454 1.3× 146 0.8× 53 0.5× 84 0.9× 81 1.1k
Austin B. Thompson United States 20 657 1.4× 306 0.8× 158 0.9× 80 0.7× 175 1.8× 40 1.2k
J. H. Alpers Australia 18 493 1.0× 310 0.9× 157 0.9× 94 0.8× 72 0.7× 43 852
Sanja Popović‐Grle Croatia 16 340 0.7× 147 0.4× 123 0.7× 67 0.6× 162 1.7× 66 703
Heung Bum Lee South Korea 15 220 0.5× 147 0.4× 102 0.6× 65 0.6× 67 0.7× 55 582
Aristea Binia Switzerland 15 290 0.6× 191 0.5× 301 1.7× 85 0.8× 221 2.3× 24 976
E M Irusen South Africa 16 253 0.5× 294 0.8× 230 1.3× 131 1.2× 85 0.9× 45 958
Makiko Jinnai Japan 21 928 1.9× 934 2.6× 130 0.7× 82 0.7× 71 0.7× 28 1.3k

Countries citing papers authored by Tomoaki Iwanaga

Since Specialization
Citations

This map shows the geographic impact of Tomoaki Iwanaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoaki Iwanaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoaki Iwanaga more than expected).

Fields of papers citing papers by Tomoaki Iwanaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoaki Iwanaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoaki Iwanaga. The network helps show where Tomoaki Iwanaga may publish in the future.

Co-authorship network of co-authors of Tomoaki Iwanaga

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoaki Iwanaga. A scholar is included among the top collaborators of Tomoaki Iwanaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoaki Iwanaga. Tomoaki Iwanaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Makoto, et al.. (2022). Impact of extrapulmonary comorbidities on physical activity in chronic obstructive pulmonary disease in Japan: A cross-sectional study. PLoS ONE. 17(7). e0270836–e0270836. 7 indexed citations
2.
Washio, Masakazu, Kyoko Kondo, Wakaba Fukushima, et al.. (2020). Hypoalbuminemia, pneumococcal vaccination and the risk of community-acquired pneumonia in the elderly: A case-control study in southern Japan. 27(1). 24–27. 1 indexed citations
3.
Miyamura, Tomoya, Tomoaki Iwanaga, Toru Masuda, et al.. (2018). Two cases of lupus retinopathy with rapid progressive visual impairment treated with multiple immunosuppressants. Modern Rheumatology Case Reports. 3(1). 14–19. 1 indexed citations
4.
Kishikawa, Reiko, Terufumi Shimoda, Akemi Saito, et al.. (2017). LONGITUDINAL MONITORING OF TREE AIRBORNE POLLEN IN JAPAN.. PubMed. 66(2). 97–111. 8 indexed citations
5.
Shimoda, Terufumi, Yasushi Obase, Yukio Nagasaka, et al.. (2017). Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. Journal of Asthma and Allergy. Volume10. 99–108. 10 indexed citations
6.
Shimoda, Terufumi, et al.. (2016). Assessment of anti-inflammatory effect from addition of a long-acting beta-2 agonist to inhaled corticosteroid. Allergy and Asthma Proceedings. 37(5). 387–393. 4 indexed citations
7.
Shimoda, Terufumi, Yasushi Obase, Yukio Nagasaka, et al.. (2016). Lung sound analysis can be an index of the control of bronchial asthma. Allergology International. 66(1). 64–69. 7 indexed citations
8.
Shimoda, Terufumi, Yasushi Obase, Yukio Nagasaka, et al.. (2016). Peripheral bronchial obstruction evaluation in patients with asthma by lung sound analysis and impulse oscillometry. Allergology International. 66(1). 132–138. 7 indexed citations
9.
Yoshida, Makoto, et al.. (2016). Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma. Pulmonary Pharmacology & Therapeutics. 42. 7–12. 15 indexed citations
10.
Shimoda, Terufumi, et al.. (2013). Association of Matrix Metalloproteinase 8 Genetic Polymorphisms with Bronchial Asthma in a Japanese Population. Allergy & Rhinology. 4(3). e132–9. 6 indexed citations
11.
12.
Okamoto, Masaki, Koichi Azuma, Tomoaki Hoshino, et al.. (2009). Correlation of Decreased Survival and IL-18 in Bone Metastasis. Internal Medicine. 48(10). 763–773. 17 indexed citations
13.
Hoshino, Tomoaki, Masaki Okamoto, Satoko Takei, et al.. (2008). Redox-Regulated Mechanisms in Asthma. Antioxidants and Redox Signaling. 10(4). 769–784. 44 indexed citations
14.
Furumoto, Akitsugu, Yasushi Ohkusa, Meng Chen, et al.. (2008). Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine. 26(33). 4284–4289. 78 indexed citations
15.
Kimura, Hiroshi, Hirohisa Toga, Hiroshi Inoue, et al.. (2006). [A questionnaire report concerning the actual situation of respiratory physicians in Japan].. PubMed. 44(4). 312–8. 2 indexed citations
16.
Inoue, Hiroshi, Yasushi Honda, Tomoaki Iwanaga, et al.. (2005). Once-Daily Administration of Fluticasone Propionate Does Not Worsen Controlled Airway Hyperresponsiveness in Patients with Asthma. Respiration. 72(5). 480–485. 3 indexed citations
17.
Iwanaga, Tomoaki, Alan R. McEuen, Andrew F. Walls, et al.. (2004). Polymorphism of the mast cell chymase gene ( CMA1 ) promoter region: lack of association with asthma but association with serum total immunoglobulin E levels in adult atopic dermatitis. Clinical & Experimental Allergy. 34(7). 1037–1042. 27 indexed citations
18.
Nakano, Hiroyuki, et al.. (2001). [The impact of obesity on oxygen desaturation in patients with sleep apnea/hypopnea syndrome].. PubMed. 39(9). 650–5. 2 indexed citations
19.
Kodama, Ken, et al.. (1990). [Problems concerning the diagnosis and treatment of multiple primary carcinoma of the lung].. PubMed. 43(9). 682–8,DISCUSSION 689. 1 indexed citations
20.
Iwanaga, Tomoaki, et al.. (1990). Rapidly Progressive Bronchiolitis Obliterans Associated with Stevens-Johnson Syndrome. CHEST Journal. 98(1). 243–245. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Cox Breakdown of academic impact, for papers by N. Barnes Breakdown of academic impact, for papers by Haruhiko Ogawa Breakdown of academic impact, for papers by Austin B. Thompson Breakdown of academic impact, for papers by J. H. Alpers Breakdown of academic impact, for papers by Sanja Popović‐Grle Breakdown of academic impact, for papers by Heung Bum Lee Breakdown of academic impact, for papers by Aristea Binia Breakdown of academic impact, for papers by E M Irusen Breakdown of academic impact, for papers by Makiko Jinnai
Rankless by CCL
2026